Erratum: Whole genome and transcriptome sequencing of matched primary and peritoneal metastatic gastric carcinoma

Gastric cancer is one of the most aggressive cancers and is the second leading cause of cancer death worldwide. Approximately 40% of global gastric cancer cases occur in China, with peritoneal metastasis being the prevalent form of recurrence and metastasis in advanced disease. Currently, there are limited clinical approaches for predicting and treatment of peritoneal metastasis, resulting in a 6-month average survival time. By comprehensive genome analysis will uncover the pathogenesis of peritoneal metastasis. Here we describe a comprehensive whole-genome and transcriptome sequencing analysis of one advanced gastric cancer case, including non-cancerous mucosa, primary cancer and matched peritoneal metastatic cancer. The peripheral blood is used as normal control. We identified 27 mutated genes, of which 19 genes are reported in COSMIC database (ZNF208, CRNN, ATXN3, DCTN1, RP1L1, PRB4, PRB1, MUC4, HS6ST3, MUC17, JAM2, ITGAD, IREB2, IQUB, CORO1B, CCDC121, AKAP2, ACAN and ACADL), and eight genes have not previously been described in gastric cancer (CCDC178, ARMC4, TUBB6, PLIN4, PKLR, PDZD2, DMBT1and DAB1).Additionally,GPX4 and MPND in 19q13.3-13.4 region, is characterized as a novel fusion-gene. This study disclosed novel biological markers and tumorigenic pathways that would predict gastric cancer occurring peritoneal metastasis.

[1]  Bonnie F. Sloane,et al.  Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ , 2013, Expert review of molecular diagnostics.

[2]  Shibing Deng,et al.  Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer , 2014, Nature Genetics.

[3]  Niranjan Nagarajan,et al.  Whole-genome reconstruction and mutational signatures in gastric cancer , 2012, Genome Biology.

[4]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[5]  R. Schulte‐Hermann,et al.  Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma , 2012, Hepatology.

[6]  R. Natrajan,et al.  From integrative genomics to therapeutic targets. , 2013, Cancer research.

[7]  Yun Deng,et al.  SFRP4 was overexpressed in colorectal carcinoma , 2010, Journal of Cancer Research and Clinical Oncology.

[8]  Kentaro Inoue,et al.  Trends in long-term survival following surgery for gastric cancer: a single institution experience. , 2004, Oncology reports.

[9]  M. Knowles,et al.  Alteration of Cell–Cell and Cell–Matrix Adhesion in Urothelial Cells: An Oncogenic Mechanism for Mutant FGFR3 , 2014, Molecular Cancer Research.

[10]  Bin Tean Teh,et al.  Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes , 2012, Nature Genetics.

[11]  E. Wang,et al.  Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. , 2014, Seminars in cancer biology.

[12]  E. Martinelli,et al.  Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer , 2012, Clinical Cancer Research.

[13]  Nam-Soon Kim,et al.  Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. , 2006, International journal of oncology.

[14]  Thomas D. Wu,et al.  Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer , 2014, Nature Communications.

[15]  J. Herman,et al.  Epigenetic changes and functional study of HOXA11 in human gastric cancer. , 2015, Epigenomics.

[16]  S. Stringer,et al.  Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes , 2012, Virchows Archiv.

[17]  F. Roviello,et al.  Prospective study of peritoneal recurrence after curative surgery for gastric cancer , 2003, The British journal of surgery.

[18]  Min Zhang,et al.  NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling , 2014, Oncotarget.

[19]  R. Brigelius-Flohé,et al.  Glutathione peroxidases in different stages of carcinogenesis. , 2009, Biochimica et biophysica acta.

[20]  Jun Zhang,et al.  A cohort study and meta-analysis between histopathological classification and prognosis of gastric carcinoma. , 2013, Anti-cancer agents in medicinal chemistry.

[21]  Ying-Yan Yu,et al.  Significance of biological resource collection and tumor tissue bank creation. , 2010, World journal of gastrointestinal oncology.

[22]  Chengzhong Xing,et al.  Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database , 2013, BMC Cancer.

[23]  L. Aaltonen,et al.  Identification of candidate oncogenes in human colorectal cancers with microsatellite instability. , 2013, Gastroenterology.

[24]  T. Kamata,et al.  Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells. , 2013, Anticancer research.

[25]  S. Lo,et al.  Incidence and Factors Associated with Recurrence Patterns after Intended Curative Surgery for Gastric Cancer , 2003, World Journal of Surgery.

[26]  Edwin Wang,et al.  Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets. , 2013, Cell reports.

[27]  V. Lemmens,et al.  Peritoneal carcinomatosis of gastric origin: A population‐based study on incidence, survival and risk factors , 2014, International journal of cancer.

[28]  H. Moussa,et al.  NKX2‐5, SIL/TAL and TLX3/HOX11L2 expression in Egyptian pediatric T‐cell acute lymphoblastic leukemia , 2016, Asia-Pacific journal of clinical oncology.

[29]  Zhenggang Zhu,et al.  Who Will Benefit from Noncurative Resection in Patients with Gastric Cancer with Single Peritoneal Metastasis? , 2014, The American surgeon.